Acrivon Therapeutics, Inc. Common Stock Profile Avatar - Palmy Investing

Acrivon Therapeutics, Inc. Common Stock

Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder ide…

Biotechnology
US, Watertown [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Acrivon Therapeutics, Inc. Common Stock has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Acrivon Therapeutics, Inc. Common Stock can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Acrivon Therapeutics, Inc. Common Stock.

End of ACRV's Analysis
CIK: 1781174 CUSIP: 004890109 ISIN: US0048901096 LEI: - UEI: -
Secondary Listings
ACRV has no secondary listings inside our databases.